Our major findings are that resting SLE T cells show an activated phenotype from the glycosylation point of view and lectin binding of activated SLE T cells is similar to the controls, with exception of the significantly lower Gal-1 binding. The gene discussed is LGALS1; the disease is systemic lupus erythematosus.